Recent Blog Posts

View Post: Effect of Bimatoprost, Latanoprost, and Unoprostone on Matrix ...
2 Nov 2009 by Ooi, YH, Oh, D.-J., Rhee, DJ  
PGAs, such as bimatoprost, latanoprost, and unoprostone, treat glaucoma by lowering intraocular pressure. They affect aqueous drainage, but vary in the degree to which uveoscleral or conventional pathways are affected.22–25 All three ...
View Blog: Investigative Ophthalmology & Visual Science... - http://www.iovs.org/

---

View Post: prostanoids. glaucoma treatment. “prostanoids have been divided ...
15 May 2009 by info@sujanani.com  
have presented an article titled: “prostanoids for the management of glaucoma.” the eye care specialists from madrid, spain, have also noted: “prostanoids have been divided into pg analogues (unoprostone, latanoprost and travoprost) and ...
View Blog: LASIK Eye Surgery - http://www.sujanani.com/lasik/lasik_surgery/

---

View Post: r-tech ueno completes enrollment in phase 2 clinical study for the ...
30 Aug 2009 by Dr. Dominique Walton Brooks  
isopropyl unoprostone was launched as a treatment for glaucoma and ocular hypertension; however, other studies have shown some neuroprotective effects of the medication along with improvements in ocular circulation. ...
View Blog: Breaking News Related to Treatment of Macular... - http://eyedocnews.com/

---

View Post: R-Tech Ueno Completes Subject Enrollment in Phase 2 Clinical Study ...
24 Aug 2009
We developed and launched isopropyl unoprostone eye-drops on the market as a drug for glaucoma and ocular hypertension in 1994. In recent studies on isopropyl unoprostone, the drug has been reported to present neuroprotective effects ...
View Blog: Latest Medical Technology from Bio-Medicine.Org - http://www.bio-medicine.org/medicine-technology-1/

---

View Post: current concept in diagnosis & management of glaucoma
11 Aug 2009 by Angel  
recent comparative studies show lataoprost to be more effective than unoprostone and timolol but less than brimatoprost.(56) bimatoprost lowered iop by 30% in approximately 78% of patients, while timolol achieved 30% reduction in only ...
View Blog: Vision Care Center - http://www.visioncarecenterpr.com/

---

View Post: Recent advances in pharmacotherapy of glaucoma Gupta SK, Galpalli ...
21 Nov 2008 by Gupta SK, Galpalli Niranjan D, Agrawal...  
A long term comparative study between topical antiglaucoma therapy of timolol and unoprostone as against betaxolol and unoprostone revealed that both combined treatments were effective for IOP reduction in glaucoma patients, ...
View Blog: Table of Contents : Indian Journal of Pharmacol... - http://www.ijp-online.com/currentissue.asp

---

View Post: section 7-c-1: prostaglandin analogs
13 Oct 2006 by FEP International  
similar agents, such as travoprost (travatan, figure 7-2 b) and bimatoprost (lumigan, figure 7-2 c), have been shown to lower iop with once daily dosing as well. unoprostone (rescula) is another prostaglandin analog; ...
View Blog: A Patients Guide to Glaucoma - http://www.medrounds.org/glaucoma-guide/

---

View Post: unoprostone is used to treat eye conditions, including glaucoma ...
29 Aug 2007 by or no longer  
unoprostone is used to treat eye conditions, including glaucoma and ocular hypertension, in which increased pressure can lead to a gradual loss of vision. unoprostone is used for patients who cannot use other eye medications for their ...
View Blog: in the eye by - http://intheeyeby.blogspot.com/

---

View Post: rescula as an alternative therapy for beta-blockers with long-term ...
4 Apr 2007 by Q  
... was to evaluate both the intraocular pressure (iop)-decreasing and neuroprotective effects of rescula (0.12% unoprostone isopropyl) as an alternative therapy to betablockers with a long-term drift effect in patients with glaucoma. ...
View Blog: The Glaucoma Blog - http://all-glaucoma.blogspot.com/

---

View Post: Sucampo Pharmaceuticals, Inc. Acquires Rights to Rescula for U.S. ...
24 Apr 2009
Rescula was approved by the U.S. Food and Drug Administration (FDA) for the treatment of open-angle glaucoma and ocular hypertension in 2000. In addition to these approved indications, Sucampo management believes that Rescula has the ... Rescula (unoprostone isopropyl) is a synthetic docosanoid that is administered topically as a liquid eye drop that activates the BK channels in cells within the retina. Sucampo management believes that this activation of BK channels ...
View Blog: BioSpace.com Featured News and Stories - http://www.biospace.com/

---